– USA, NJ – Comar, a premier supplier of custom molded medical devices and assemblies and specialty packaging solutions, today announced the appointment of Brian Larkin as its new President and CEO, succeeding Mike Ruggieri, who will remain on the Board of Directors as Chairman.
“Brian is the right leader for Comar. Brian’s extensive background in the healthcare industry combined with his innate business development skills should help Comar strengthen partnerships, develop strategic alliances, and expand our international sales presence. In addition, we believe his customer-centric leadership style will help focus Comar as we pursue our strategic ambitions,” said Board Chairman, Mike Ruggieri.
About Brian Larkin
His career spans more than three decades of commercial and executive leadership roles in public and private equity-backed companies focused on medical device and pharmaceutical companies. Prior to joining Comar, Brian Larkin held several key executive positions, including President and CEO of SP Industries, VP and GM of Becton Dickinson’s U.S. Diabetes Care business, SVP and GM for LifeCell Corporation, and Corporate VP of Integra Lifesciences. He also currently serves on the Board of Directors for Dynatronics Corporation.
“I am excited to build upon the strong foundation that Mike and his team have established at Comar and eager to contribute to its next phase of growth,” said Brian Larkin. “I look forward to partnering with Comar’s employees and valued customers to capitalize on emerging growth trends in the medical and packaging industries while continuing to provide the highest quality products and services.”
About Comar
Comar, headquartered in Voorhees, NJ, has 11 strategic manufacturing and distribution locations and employs a host of plastic molding technologies, including injection molding, injection blow molding, injection stretch blow molding, and extrusion blow molding, which are complemented by a full suite of value-added service offerings. For over 70 years, Comar has partnered with clients to launch high-impact packaging and medical solutions—transforming them from concept to reality, where they can positively impact the world around us. Comar is majority-owned by Morgan Stanley Capital Partners.
For more information: https://www.comar.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
